BINDER, Bernd

On August 28, 2010, Professor Bernd Binder, head of the Center of Physiology and Pharmacology at the Medical University of Vienna, Austria, died after a long illness.

Obituary

2008 Impact Factor announced

We are delighted that the JTH Impact Factor has risen to 6.291. The impact factor underlines the Journal's status as the number one specialist Journal in thrombosis and haemostasis research. Below is a chart showing the Journal's growing impact factor since its inception.

Changes to JTH word and author limits.

At the 2009 ISTH Congress in Boston, the Editorial Board agreed a relaxing of the policy on word limits for Original Articles and on author limits for Letters to the Editors. It is expected that the majority of Original Articles will continue to be up to 5000 words long including all references and figure legends. However, articles of exceptional quality will be considered which exceed this limit (usually up to 5000 words excluding references and figure legends). The editors also agreed that high quality Letters to the Editors will be considered with up to eight authors. These changes are effective immediately.

2009 Pier M. Mannucci Young Investigator prizewinners

The Mannucci Prizes are awarded in honour of Pier M. Mannucci, the Journal's first Editor-in-Chief, for the best articles by Young Investigators under 35 years of age. The prizes are made possible by a generous contribution from Bayer HealthCare.

The 2009 prizes were awarded to:

• Carsten Baldauf for the article Shear-induced unfolding activates von Willebrand factor A2 domain for proteolysis (Volume 7, Issue 12 pp. 2096-2105)
• Jianguo Wang for the article Levels of microparticle tissue factor activity correlate with coagulation activation in endotoxemic mice (Volume 7, Issue 7 pp. 1092-1098)
• Kannan Meganathan for the article Molecular defects in ITGA2B and ITGB3 genes in patients with Glanzmann thrombasthenia (Volume 7, Issue 11 pp. 1878-1885)
• Tatiana Lobo for the article Ixolaris, a tissue factor inhibitor, blocks primary tumor growth and angiogenesis in a glioblastoma model (Volume 7, Issue 11 pp. 1855-1864)
• Adam Rose for the article Warfarin dose management affects INR control (Volume 7, Issue 1 pp. 94-101)

We wish to congratulate the authors for their achievement.

HASLAM, Richard John
We sadly announce that Dr. Richard Haslam died in Hamilton, Ontario on May 15, 2009 at the age of 71 years, after a long illness. Born in Wigton, Cumberland, England, Richard was an internationally respected scientist who pioneered much of the work on platelet activation pathways. One of the last PhD students of Hans Krebs in Oxford; his life's work centered on the area of signal transduction, including the roles of GTP-binding proteins, phospholipases, protein kinases and cyclic nucleotides in the regulation of cell function. He is perhaps best known for cloning the major substrate for protein kinase C in platelets, and naming this pleckstrin, a term now used in all major biochemical textbooks when referring to pleckstrin homology domains. The focus of his work was on cells important in cardiovascular disease, particularly blood platelets. While some of his early work was performed at the Royal College of Surgeons and with I.C.I. Pharmaceuticals in Alderley Park, England, he soon began an association with McMaster University that led to his permanent recruitment in 1972. He was appointed Professor Emeritus in McMaster University in 2003 and had remained active in research. He was universally recognized for the originality, quality and thoroughness of his research and in total published over 70 primary papers, including 7 in Nature. His wife Beryl, their three children, and his many colleagues in Canada and around the world will sorely miss Richard.
Alan Nurden and Steve Watson

2007 Pier M. Mannucci Young Investigator prizewinners

The Mannucci Prizes are awarded in honour of Pier M. Mannucci, the Journal's first Editor-in-Chief, for the best articles by Young Investigators under 35 years of age. The prizes are made possible by a generous contribution from Bayer HealthCare.

The 2007 prizes were awarded to:

• Mr S Calaminus (UK) for the article 'MyosinIIa contractility is required for maintenance of platelet structure during spreading on collagen and contributes to thrombus stability' (October)
• Dr E Ceresa (Belgium) for the article 'Comparative evaluation of stable TAFIa variants: importance of a-helix 9 and b-sheet 11 for TAFIa (in)stability' (October)
• Dr S Gouw (the Netherlands) for the article 'Treatment characteristics and the risk of inhibitor development: a multicenter cohort study among previously untreated patients with severe hemophilia A' (July)
• Dr Y Kozuma (Japan) for the article 'Continuous expression of Bcl-xL protein during megakaryopoiesis is post-translationally regulated by thrombopoietin-mediated Akt activation, which prevents the cleavage of Bcl-xL' (June)
• Dr H Lemmerhirt (USA) for the article 'Genetic regulation of plasma von Willebrand factor levels: quantitative trait loci analysis in a mouse model' (February)
• Dr X Zheng (USA) for the article 'Non-hematopoietic EPCR regulates the coagulation and inflammatory responses during endotoxemia' (July)

We wish to congratulate the authors for their achievement.

good news for authors about the printing of colour figures

From 2008, colour figures in JTH will be charged at a rate of US $500 per page. This is a reduction from the previous fee of $800 per page.

We are also pleased to announce Colour on the Web. This free service enables authors to publish in black and white in the printed journal but in full colour in the online version. Authors wishing to take advantage of this service need only inform the editorial office upon acceptance of their manuscript.